Show simple item record

dc.contributor.authorClarke, Noel W
dc.contributor.authorWylie, James P
dc.date.accessioned2009-08-20T11:01:07Z
dc.date.available2009-08-20T11:01:07Z
dc.date.issued2004-12
dc.identifier.citationChemotherapy in hormone refractory prostate cancer: where do we stand? 2004, 46 (6):709-11 Eur. Urol.en
dc.identifier.issn0302-2838
dc.identifier.pmid15548436
dc.identifier.doi10.1016/j.eururo.2004.08.023
dc.identifier.urihttp://hdl.handle.net/10541/77992
dc.language.isoenen
dc.subjectProstatic Canceren
dc.subject.meshAntineoplastic Agents, Hormonal
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshProstatic Neoplasms
dc.subject.meshTreatment Failure
dc.titleChemotherapy in hormone refractory prostate cancer: where do we stand?en
dc.typeArticleen
dc.contributor.departmentDepartment of Surgery, Christie Hospital, Manchester M20 4BX, UKen
dc.identifier.journalEuropean Urologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record